Showa University Hospital

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.3K citations · Full text

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +7

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Francesca Tentori, Margaret J. Blayney, Justin M. Albert et al. · American Journal of Kidney Diseases · 2008 · 1.1K citations

Hemodialysis, Urology, Renal Function +10

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Jean Bousquet, Holger J. Schünemann, Bolesław Samoliński et al. · Journal of Allergy and Clinical Immunology · 2012 · 628 citations · Full text

Asthma, Allergy, Allergy Medicine +5

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung et al. · The Lancet · 2022 · 580 citations · Full text

Breast Oncology, Medicine, Clinical Trials +8